Tuesday, July 27, 2021

Biocon partners Adagio for licence to make Covid-19 antibody cocktail

Treatment claims to address the resistant Delta variant as well

from Today's Paper https://ift.tt/3rIeyqv
via
By at
Labels: ,

No comments:

Post a Comment

If you have any doubts please let me know!

Subscribe to: Post Comments (Atom)

India's low score on GVC a starting point for recovery from pandemic: AIIB

India rated 7.4 percentage points below the average global value chain participation rate for emerging economies from Today's Paper ht...